Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Yungjin Pharm financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

₩2.4 K

2024-10-29

Market Capitalization

₩437.1 B

2024-10-29

Revenue

₩252 B

FY, 2024

CreditSafe Score

?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

KRWFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024
Revenue186.4B220.5B208.5B196.1B218.4B234.9B252.0B
Cost of goods sold99.2B113.8B88.5B111.2B124.2B155.3B164.2B
Gross profit87.5B107.1B120.3B85.2B94.6B79.7B90.5B
Gross profit margin, %46.9%48.6%57.7%43.4%43.3%33.9%35.9%
Operating expense total82.8B90.4B111.8B91.4B93.7B67.8B70.4B
Depreciation and amortization11.5B6.4B7.8B7.4B7.8B11.2B9.5B
EBITDA4.7B16.7B8.4B(6.2B)867.5M11.9B20.1B
EBITDA margin, %2.5%7.6%4.1%-3.2%0.4%5.1%8.0%
EBIT(6.8B)9.8B497.4M(13.6B)(21.2B)(803.5M)8.3B
EBIT margin, %-3.6%4.5%0.2%-6.9%-9.7%-0.3%3.3%
Interest income135.8M2.3M2.6M2.4M2.7M11.3M286.4M
Interest expense272.6M254.5M253.2M209.0M736.6M2.9B5.3B
Pre tax profit(6.7B)9.4B241.3M(14.1B)(22.8B)(3.9B)2.9B
Income tax expense(550.6M)4.4B374.4M(2.6B)(851.7M)(42.4M)1.7B
Net Income(6.1B)5.0B(133.1M)(11.6B)(22.0B)(3.9B)1.2B

Footer menu